Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes

Glycobiology

Volumn 23, Issue 11, 2013, Pages 1281-1292

  Yu, Zhuo Teng ^a   Chen, Ceng ^a   Newburg, David S ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

Commensal bacteria; Glycosidase; Human milk oligosaccharides; Mutualist bacteria; Organic acids

Indexed keywords

ALPHA LEVO FUCOSIDASE; HUMAN MILK OLIGOSACCHARIDE; LACTIC ACID; OLIGOSACCHARIDE; SHORT CHAIN FATTY ACID; SIALIDASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; BIFIDOBACTERIUM LONGUM; CLOSTRIDIUM; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENZYME ACTIVITY; ESCHERICHIA COLI K 12; FERMENTATION; FUCOSYLATION; INTESTINE FLORA; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PH; PRIORITY JOURNAL; SIALYLATION; STAPHYLOCOCCUS; STREPTOCOCCUS THERMOPHILUS;

COMMENSAL BACTERIA; GLYCOSIDASE; HUMAN MILK OLIGOSACCHARIDES; MUTUALIST BACTERIA; ORGANIC ACIDS;

ALPHA-L-FUCOSIDASE; BACTERIAL PROTEINS; BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM; CULTURE MEDIA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI K12; FUCOSE; GASTROINTESTINAL TRACT; GLYCOSYLATION; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS DELBRUECKII; MICROBIOTA; MILK, HUMAN; OLIGOSACCHARIDES; SIALIC ACIDS; STREPTOCOCCUS THERMOPHILUS;

EID: 84886032272     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt065     Document Type: Article

References (42)

1. Almagro-Moreno S, Boyd EF. 2009a. Insights into the evolution of sialic acid catabolism among bacteria. BMC Evol Biol. 9:118.
2. Almagro-Moreno S, Boyd EF. 2009b. Sialic acid catabolism confers a competitive advantage to pathogenic Vibrio cholerae in the mouse intestine. Infect Immun. 77:3807-3816.
3. Angeloni S, Ridet JL, Kusy N, Gao H, Crevoisier F, Guinchard S, Kochhar S, Sigrist H, Sprenger N. 2005. Glycoprofiling with micro-arrays of glycoconjugates and lectins. Glycobiology. 15:31-41. (Pubitemid 40202037)
4. Augenlicht LH, Anthony GM, Church TL, Edelmann W, Kucherlapati R, Yang K, Lipkin M, Heerdt BG. 1999. Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. Cancer Res. 59:6005-6009. (Pubitemid 30004965)
5. Boehm G, Stahl B. 2007. Oligosaccharides from milk. J Nutr. 137:847S-849S. (Pubitemid 46397528)
6. Chang DE, Smalley DJ, Tucker DL, Leatham MP, Norris WE, Stevenson SJ, Anderson AB, Grissom JE, Laux DC, Cohen PS, et al. 2004. Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci USA. 101:7427-7432. (Pubitemid 38638049)
7. Chichlowski M, German JB, Lebrilla CB, Mills DA. 2011. The influence of milk oligosaccharides on microbiota of infants: Opportunities for formulas. Ann Rev Food Sci Technol. 2:331-351.
8. Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, Capretti R, Orazio G. 2006. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res. 59:377-382. (Pubitemid 43740074)
9. Gauhe A, Gyorgy P, Hoover JRE, Kuhn R, Rose CS. 1954. Bifidus factor. IV. Preparations obtained from human milk. Arch Biochem Biophys. 48: 214-224.
10. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, Nelson KE, White O, Methe BA, Huttenhower C. 2012. The human microbiome project: A community resource for the healthy human microbiome. PLoS Biol. 10:e1001377.
11. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. 2004. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr Res Rev. 17:259-275.
12. Gyorgy P, Jeanloz RW, von Nicolai H, Zilliken F. 1974. Undialyzable growth factors for Lactobacillus bifidus var. pennsylvanicus. Protective effect of sialic acid bound to glycoproteins and oligosaccharides against bacterial degradation. Eur J Biochem. 43:29-33.
13. Kunz C, Rudloff S, Baier W, Klein N, Strobel S. 2000. Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Ann Rev Nutr. 20:699-722.
14. LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla CB, Mills DA, German JB. 2007. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem. 55:8914-8919. (Pubitemid 350105536)
15. LoCascio RG, Ninonuevo MR, Kronewitter SR, Freeman SL, German JB, Lebrilla CB, Mills DA. 2009. Aversatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb Biotechnol. 2:333-342.
16. Marcobal A, Barboza M, Froehlich JW, Block DE, German JB, Lebrilla CB, Mills DA. 2010. Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem. 58:5334-5340.
17. Marcobal A, Barboza M, Sonnenburg ED, Pudlo N, Martens EC, Desai P, Lebrilla CB, Weimer BC, Mills DA, German JB, et al. 2011. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe. 10:507-514.
18. Moro E. 1900. Morphologische und bakterogische untersuchungen uber die Dambakterien des Saulings: Die bacterium flora des normalen frauenmilch stuhls. Fabb Kinderbeilkd. 61:686-734.
19. Nanthakumar NN, Meng D, Newburg DS. 2013. Glucocorticoids and microbiota regulate ontogeny of intestinal fucosyltransferase 2 requisite for gut homeostasis. Glycobiology. In press.
20. Newburg DS. 1996. Oligosaccharides and glycoconjugates in human milk: Their role in host defense. J Mammary Gland Biol Neoplasia. 1:271-283.
21. Newburg DS. 2000. Are all human milks created equal? Variation in human milk oligosaccharides. J Pediatr Gastroenterol Nutr. 30:131-133. (Pubitemid 30366187)
22. Newburg DS. 2001. Bioactive Components of Human Milk. Waltham: Kluwer Academic/Plenum Publishers.
23. Newburg DS, Daniel PF, O'Neil NE, McCluer RH. 1986. High performance liquid chromatography of oligosaccharides from human milk and colostrum. In: Hamosh M, Goldman AS, editors. Human Lactation 2: Maternal and Environmental Factors. New York: Plenum Press. p. 581-588.
24. Newburg DS, Neubauer SH. 1995. Handbook of Milk Composition. San Diego: Academic Press.
25. Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Guerrero ML, Meinzen-Derr JK, Morrow AL. 2004. Human milk alphal,2-linked fucosylated oligosaccharides decrease risk of diarrhea due to stable toxin of E. coli in breastfed infants. Adv Exp Med Biol. 554:457-461. (Pubitemid 39304559)
26. Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Meinzen-Derr J, Guerrero Mde L, Morrow AL. 2004. Innate protection conferred by fucosylated oligosaccharides of human milk against diarrhea in breastfed infants. Glycobiology. 14:253-263. (Pubitemid 38324941)
27. Newburg DS, Ruiz-Palacios GM, Morrow AL. 2005a. Human milk glycans protect infants against enteric pathogens. Ann Rev Nutr. 25:37-58. (Pubitemid 41208993)
28. Newburg DS, Ruiz-Palacios GM, Morrow AL. 2005b. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr. 25:37-58. (Pubitemid 41208993)
29. Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, Clowers BH, German JB, Freeman SL, Killeen K, Grimm R, et al. 2006. A strategy for annotating the human milk glycome. J Agric Food Chem. 54:7471-7480. (Pubitemid 44645760)
30. Ogawa K, Ben RA, Pons S, de Paolo MI, Bustos Fernandez L. 1992. Volatile fatty acids, lactic acid, and pH in the stools of breast-fed and bottle-fed infants. J Pediatr Gastroenterol Nutr. 15:248-252.
31. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. 2003. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem. 278:14112-14120. (Pubitemid 36799958)
32. Schack-Nielsen L, Michaelsen KF. 2007. Advances in our understanding of the biology of human milk and its effects on the offspring. J Nutr. 137: 503S-510S. (Pubitemid 46213473)
33. Sela DA, Li Y, Lerno L, Wu S, Marcobal AM, German JB, Chen X, Lebrilla CB, Mills DA. 2011. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J Biol Chem. 286:11909-11918.
34. Sela DA, Mills DA. 2010. Nursing our microbiota: Molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol. 18: 298-307.
35. Simon PM, Goode PL, Mobasseri A, Zopf D. 1997. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun. 65:750-757. (Pubitemid 27053248)
36. Sohanpal BK, El-Labany S, Lahooti M, Plumbridge JA, Blomfield IC. 2004. Integrated regulatory responses of fimB to N-acetylneuraminic (sialic) acid and GlcNAc in Escherichia coli K-12. Proc Natl Acad Sci USA. 101:16322-16327. (Pubitemid 39552843)
37. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. 2006. In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl Environ Microbiol. 72:4497-4499. (Pubitemid 43894931)
38. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB. 2007. In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res. 51:1398-1405. (Pubitemid 350195613)
39. Weiss GA, Hennet T. 2012. The role of milk sialyllactose in intestinal bacterial colonization. Adv Nutr. 3:483S-488S.
40. Wiederschain GY, Newburg DS. 1996. Compartmentalization of fucosyltransferase and alpha-L-fucosidase in human milk. Biochem Mol Med. 58: 211-220. (Pubitemid 26262365)
41. Yu ZT, Chen C, Kling DE, Liu B, McCoy JM, Merighi M, Heidtman M, Newburg DS. 2013. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology. 23:169-177.
42. Zhang G, Mills DA, Block DE. 2009. Development of chemically defined media supporting high-cell-density growth of lactococci, enterococci, and streptococci. Appl Environ Microbiol. 75:1080-1087.